scholarly journals Unexpected drug residuals in human milk in Ankara, capital of Turkey

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Ayşe Meltem Ergen ◽  
Sıddıka Songül Yalçın
Keyword(s):  
Breast Milk ◽  
Postpartum Depression ◽  
Maternal Body Mass Index ◽  
Lactation Period ◽  
Drug Residues ◽  
Inflammatory Drug ◽  
Breastfed Infants ◽  
Sleeping Problems ◽  
Anti Inflammatory ◽  
The Impact

Abstract Background Breast milk is a natural and unique nutrient for optimum growth and development of the newborn. The aim of this study was to investigate the presence of unpredictable drug residues in mothers’ milk and the relationship between drug residues and maternal-infant characteristics. Methods In a descriptive study, breastfed infants under 3 months of age and their mothers who applied for child health monitoring were enrolled for the study. Information forms were completed for maternal-infant characteristics, breastfeeding problems, crying and sleep characteristics of infants. Maternal and infant anthropometric measurements and maternal milk sample were taken. Edinburgh Postpartum Depression Scale was applied to mothers. RANDOX Infiniplex kit for milk was used for residual analysis. Results Overall, 90 volunteer mothers and their breastfed infants were taken into the study and the mean age of the mothers and their infants was 31.5 ± 4.2 years and 57.8 ± 18.1 days, respectively. Anti-inflammatory drug residues in breast milk were detected in 30.0% of mothers and all had tolfenamic acid. Overall, 94.4% had quinolone, 93.3% beta-lactam, 31.1% aminoglycoside and 13.3% polymycin residues. Drugs used during pregnancy or lactation period were not affected by the presence of residues. Edinburgh postpartum depression scores of mothers and crying and sleeping problems of infants were similar in cases with and without drug residues in breast milk. When controlling confounding factors, maternal body mass index alterations were detected to be significantly lower in mothers with anti-inflammatory drug residues in breast milk than in their counterparts (p = 0.017). Conclusions Our study suggests that there are unpredictable drug residues in the milk of many mothers. Anti-inflammatory drug exposure might affect maternal weight change during the postpartum period. Further studies are required to evaluate the impact of drug residues on maternal and infant health.

scholarly journals Dynamic Associations of Milk Components With the Infant Gut Microbiome and Fecal Metabolites in a Mother–Infant Model by Microbiome, NMR Metabolomic, and Time-Series Clustering Analyses

2022 ◽  
Vol 8 ◽  
Author(s):  
Yosuke Komatsu ◽  
Daiki Kumakura ◽  
Namiko Seto ◽  
Hirohisa Izumi ◽  
Yasuhiro Takeda ◽  
...  
Keyword(s):  
Breast Milk ◽  
Gut Microbiome ◽  
Lactation Period ◽  
Bioactive Components ◽  
Fecal Microbiome ◽  
Breastfed Infants ◽  
H Nmr ◽  
Milk Components ◽  
Infant Gut Microbiome ◽  
Infant Feces

Background: The gut microbiome and fecal metabolites of breastfed infants changes during lactation, and are influenced by breast milk components. This study aimed to investigate dynamic associations of milk components with the infant gut microbiome and fecal metabolites throughout the lactation period in a mother–infant model.Methods: One month after delivery, breast milk and subsequent infant feces were collected in a pair for 5 months from a mother and an exclusively breastfed infant. Composition of the fecal microbiome was determined with 16S rRNA sequencing. Low-molecular-weight metabolites, including human milk oligosaccharides (HMOs), and antibacterial proteins were measured in feces and milk using 1H NMR metabolomics and enzyme-linked immunosorbent assays. The association of milk bioactive components with the infant gut microbiome and fecal metabolites was determined with Python clustering and correlation analyses.Results: The HMOs in milk did not fluctuate throughout the lactation period. However, they began to disappear in infant feces at the beginning of month 4. Notably, at this time-point, a bifidobacterium species switching (from B. breve to B. longum subsp. infantis) occurred, accompanied by fluctuations in several metabolites including acetate and butyrate in infant feces.Conclusions: Milk bioactive components, such as HMOs, might play different roles in the exclusively breastfed infants depending on the lactation period.

THE IMPACT OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG USE ON PROGNOSIS IN PATIENTS HOSPITALIZED FOR ACUTE HEART FAILURE

2020 ◽  
Vol 75 (11) ◽  
pp. 909
Author(s):  
Thiratest Leesutipornchai ◽  
Thanaporn Ratchataswan ◽  
Palapun Waitayangkoon ◽  
Aunchalee Jaroenlapnopparat ◽  
Supanee Sinphurmsukskul ◽  
...  
Keyword(s):  
Heart Failure ◽  
Drug Use ◽  
Acute Heart Failure ◽  
Inflammatory Drug ◽  
Anti Inflammatory ◽  
The Impact

scholarly journals Human Milk Oligosaccharides (HMOs) and Infant Microbiota: A Scoping Review

Foods ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 1429
Author(s):  
Cristina Sánchez ◽  
Cristina Fente ◽  
Patricia Regal ◽  
Alexandre Lamas ◽  
María Paz Lorenzo
Keyword(s):  
Breast Milk ◽  
Human Milk ◽  
Mode Of Delivery ◽  
Geographic Location ◽  
Microbial Colonization ◽  
Human Milk Oligosaccharides ◽  
Maternal Factors ◽  
Milk Oligosaccharides ◽  
Breastfed Infants ◽  
The Impact

Human milk oligosaccharides (HMOs) are the third most abundant solid component of breast milk. However, the newborn cannot assimilate them as nutrients. They are recognized prebiotic agents (the first in the newborn diet) that stimulate the growth of beneficial microorganisms, mainly the genus Bifidobacterium, dominant in the gut of breastfed infants. The structures of the oligosaccharides vary mainly according to maternal genetics, but also other maternal factors such as parity and mode of delivery, age, diet, and nutritional status or even geographic location and seasonality cause different breast milk oligosaccharides profiles. Differences in the profiles of HMO have been linked to breast milk microbiota and gut microbial colonization of babies. Here, we provide a review of the scope of reports on associations between HMOs and the infant gut microbiota to assess the impact of HMO composition.

scholarly journals Early Life Microbiota Colonization at Six Months of Age: A Transitional Time Point

2021 ◽  
Vol 11 ◽  
Author(s):  
Benedetta Raspini ◽  
Mirco Vacca ◽  
Debora Porri ◽  
Rachele De Giuseppe ◽  
Francesco Maria Calabrese ◽  
...  
Keyword(s):  
Gut Microbiota ◽  
Early Life ◽  
Maternal Body Mass Index ◽  
Microbiota Composition ◽  
Fecal Samples ◽  
Breastfed Infants ◽  
Gestational Weight ◽  
Significant Difference ◽  
The Impact ◽  
Older Siblings

BackgroundEarly life gut microbiota is involved in several biological processes, particularly metabolism, immunity, and cognitive neurodevelopment. Perturbation in the infant’s gut microbiota increases the risk for diseases in early and later life, highlighting the importance of understanding the connections between perinatal factors with early life microbial composition. The present research paper is aimed at exploring the prenatal and postnatal factors influencing the infant gut microbiota composition at six months of age.MethodsGut microbiota of infants enrolled in the longitudinal, prospective, observational study “A.MA.MI” (Alimentazione MAmma e bambino nei primi MIlle giorni) was analyzed. We collected and analyzed 61 fecal samples at baseline (meconium, T0); at six months of age (T2), we collected and analyzed 53 fecal samples. Samples were grouped based on maternal and gestational weight factors, type of delivery, type of feeding, time of weaning, and presence/absence of older siblings. Alpha and beta diversities were evaluated to describe microbiota composition. Multivariate analyses were performed to understand the impact of the aforementioned factors on the infant’s microbiota composition at six months of age.ResultsDifferent clustering hypotheses have been tested to evaluate the impact of known metadata factors on the infant microbiota. Neither maternal body mass index nor gestational weight gain was able to determine significant differences in infant microbiota composition six months of age. Concerning the type of feeding, we observed a low alpha diversity in exclusive breastfed infants; conversely, non-exclusively breastfed infants reported an overgrowth of Ruminococcaceae and Flavonifractor. Furthermore, we did not find any statistically significant difference resulting from an early introduction of solid foods (before 4 months of age). Lastly, our sample showed a higher abundance of clostridial patterns in firstborn babies when compared to infants with older siblings in the family.ConclusionOur findings showed that, at this stage of life, there is not a single factor able to affect in a distinct way the infants’ gut microbiota development. Rather, there seems to be a complex multifactorial interaction between maternal and neonatal factors determining a unique microbial niche in the gastrointestinal tract.

Sign in / Sign up

Export Citation Format

Share Document